Which lab value indicates an increased risk for an infusion reaction for a patient with lymphoma who is scheduled to receive rituximab?
a. ANC 6,500mm3
b. platelet count 100,000mm3
c. circulating lymphocytes 30,000mm3
d. hematocrit 35%
Option (c) , circulating lymphocytes 30,000 mm3
As , RITUXIMAB can cause severe fatal , infusion related reaction .Severe reaction typically occured during the first infusion with time to onset of 30 to 120 minutes. That s why it is closely monitor the following patient ;- those with pre- existing cardiac or pulmonary conditions and those who are experienced prior cardiopulmonary adverse reaction and especially those with high numbers of circulating malignant cells like lymphoma ( above or equal to 25,000/mm3) .
Get Answers For Free
Most questions answered within 1 hours.